Costs of polio immunization days in China: implications for mass immunization campaign strategies

Int J Health Plann Manage. 1998 Jan-Mar;13(1):5-25. doi: 10.1002/(SICI)1099-1751(199801/03)13:1<5::AID-HPM497>3.0.CO;2-8.

Abstract

Ten provinces of China were selected to estimate the cost per immunization of the 1994-95 national immunization days (NIDs) at five levels (e.g. province, prefecture, county, township and village). Personnel costs accounted for the largest overall share of costs (39 per cent), followed by publicity and promotion costs (27 per cent), and logistic costs (15 per cent). Without consideration of vaccine costs, the major part of NID expenses were shouldered at the township level, which paid for 47 per cent of all incremental costs, while county and village level covered 28 per cent and 18 per cent respectively. Estimation of average costs per immunization was 2.86 RMB yuan, or $0.34, including vaccine costs, buildings and equipment amortization and salaries at all levels. The factors affecting average cost of NID included the output volume, socio-economic development and geographic features. Various approaches were recommended: to intensify the productivity of time and staff, to employ alternative inexpensive manpower resources, to make the best use of publicity and social promotion, the expansion of the age groups and utilization of multi-intervention strategies. Good planning at township level was a decisive factor to ensure an effective NID conducted in an efficient manner. The average cost of China's NID was the lowest among all mass immunization campaigns ever documented. Much of the reduced average cost was attributable to economies of scale.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catchment Area, Health / economics
  • China
  • Developing Countries
  • Drug Costs
  • Health Care Costs / statistics & numerical data*
  • Health Care Surveys
  • Humans
  • Immunization Programs / economics*
  • Poliomyelitis / prevention & control*
  • Public Health Administration
  • Vaccines / economics*

Substances

  • Vaccines